Diamyd Gets $3M to Develop Treatment for Chemotherapy-Induced PN

Diamyd Medical and the University of Michigan have been awarded a $3M three-year NIH grant to develop a product for use in preventing chemo-induced neuropathy. The product could be administered to cancer patients before they start chemotherapy treatments. READ MORE

Source: Genetic Engineering & Biotechnology News

Join us in improving the lives of peripheral neuropathy patients.
Send this to a friend